A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.
Collaborative research center funded by Lisa Yang and Hock Tan ’75 blends engineering and neuroscience to advance molecular tools for treating brain disorders.
Applied computational biology discoveries vastly expand the range of CRISPR’s access to DNA sequences.
New CRISPR-based research tool delivers results in an hour; researchers share protocol and kits to advance research and move toward clinical validation.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
Globally respected cell biologist will be the Whitehead Institute’s inaugural Landon T. Clay Professor of Biology and a professor of biology at MIT.
Neuroscientists identify genes that modulate the disease’s toxic effects.
Researchers find master regulator needed for Toxoplasma gondii parasite to chronically infect host; promising step toward infection treatment, prevention.
James Collins, Pablo Jarillo-Herrero, and Richard Milner have won top prizes for their work.
Engineers program human and bacterial cells to keep a record of complex molecular events.
The new system, dubbed RESCUE, allows RNA edits to be made that were not previously possible.
By introducing a gene variant associated with autism into monkeys, researchers hope to study treatment options for severe neurodevelopmental disorders.